NF-κB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance.

NF-κB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance.

Item
http://www.wikidata.org/entity/Q37173070
Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c.Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.Loss of TAB3 expression by shRNA exhibits suppressive bioactivity and increased chemical sensitivity of ovarian cancer cell lines via the NF-κB pathway.MicroRNA-targeted therapeutics for lung cancer treatment.Marsdenia tenacissima extract overcomes Axl- and Met-mediated erlotinib and gefitinib cross-resistance in non-small cell lung cancer cells.miR-155 mediates arsenic trioxide resistance by activating Nrf2 and suppressing apoptosis in lung cancer cells.Exosome-mediated breast cancer chemoresistance via miR-155 transfer.miR-155 in cancer drug resistance and as target for miRNA-based therapeutics.Fine tuning of FOXO3A in cHL as a survival mechanism and a hallmark of abortive plasma cell differentiation.PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression.Roles of NF-κB Signaling in the Regulation of miRNAs Impacting on Inflammation in Cancer.NF-κB-driven improvement of EHD1 contributes to erlotinib resistance in EGFR-mutant lung cancers.Emerging application of genomics-guided therapeutics in personalized lung cancer treatment.Genomic Profiling on an Unselected Solid Tumor Population Reveals a Highly Mutated Wnt/β-Catenin Pathway Associated with Oncogenic EGFR Mutations.Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer
P2860

NF-κB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance.

Item
http://www.wikidata.org/entity/Q37173070
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
NF-κB-driven suppression of FO ...... ependent gefitinib resistance.
@en
NF-κB-driven suppression of FO ...... ependent gefitinib resistance.
@nl
type
label
NF-κB-driven suppression of FO ...... ependent gefitinib resistance.
@en
NF-κB-driven suppression of FO ...... ependent gefitinib resistance.
@nl
prefLabel
NF-κB-driven suppression of FO ...... ependent gefitinib resistance.
@en
NF-κB-driven suppression of FO ...... ependent gefitinib resistance.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
NF-κB-driven suppression of FO ...... dependent gefitinib resistance
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932